Diagnosis and Molecular Characterization of Nonclassic Forms of Tay-Sachs Disease in Brazil

Abstract

Molecular analysis of five Brazilian families, including eight patients presenting with nonclassic Tay-Sachs disease, was performed to identify frequent causative mutations and their correlation with clinical course. Three patients were affected by the B1 subacute variant and were shown to carry the R178H mutation (the DN allele), which is also common among Portuguese patients. Two of them were compound heterozygotes, whereas the third presented with the mutation in both alleles. Since Brazil was a Portuguese colony for over two centuries, common ancestry might be the probable explanation. The fourth patient presented with a juvenile phenotype and carries the R499H mutation, which has been reported only once worldwide and is associated with residual enzyme activity, responsible for a slower clinical course. The fifth family, of an Ashkenazi Jewish background, showed an extensive intrafamilial clinical variability among three affected sibs presenting with muscle atrophy, ataxia, and psychiatric symptoms. They were first diagnosed as having atypical spinal muscular atrophy and, subsequently, spinocerebellar ataxia, but, recently, the diagnosis of late-onset Tay-Sachs disease was confirmed based on reduced plasma hexosaminidase A activity and the G269S/InsTATC1278 genotype. It is therefore highly recommended to test patients with a similar clinical history for Tay-Sachs disease. In the same family, one first cousin committed suicide at the age of 24 years, presenting with a clinical phenotype that suggested an undiagnosed case and highlighting the effect of the intrafamilial clinical variability in delaying a prompt diagnosis. It is now recognized that his parents are, in fact, a carrier couple. Additionally, another relative had been previously identified as a heterozygote in a Tay-Sachs disease screening program, but the information was not shared among the family. Since this information might anticipate diagnosis and genetic counseling, it is advisable that heterozygote screening programs encourage families to share genetic information. (J Child Neurol 2006;21:540—544; DOI 10.2310/7010.2006.00102).

Get full access to this article

View all access options for this article.

References

Gravel RA , Clarke JT , Kaback MM , et al: The GM2 gangliosidosis, in: Scriver CR , Beaudet AL , Sly WS , Valle DV (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001, 3827—3876.

Conzelmann E. , Kytzia HJ , Navon R. , Sandhoff K. : Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet 1983;35:900—913.

MacQueen GM , Rosebush PI , Mazurek MF : Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1998;10:10—19.

Navon R. , Argov Z. , Frisch A. : Hexosaminidase A deficiency in adults. Am J Med Genet 1986;24:179—196.

Navon R. , Proia RL : The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 1989;243:1471—1474.

Tutor JC : Biochemical characterization of the GM2 gangliosidosis B1 variant. Braz J Med Biol Res 2004;37:777—783.

Triggs-Raine B. , Feingenbaum Asj , Natowicz MR , et al: Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests . N Engl J Med 1990;323:6—12.

Hechtman P. , Kaplan F. : Tay-Sachs disease screening and diagnosis: Evolving technologies. DNA Cell Biol 1993;12:651—665.

Rozenberg R. , Martins AM , Micheletti C. , et al: Tay-Sachs disease in Brazilian patients: Prevalence of the IVS7+1g>c mutation. J Inherit Metab Dis 2004;27:109—110.

10.

Santos MR , Tanaka A. , Miranda Mcs , et al: GM2 gangliosidosis B1 variant: Analysis of β-hexosaminidase A gene mutations in 11 patients from a defined region in Portugal. Am J Hum Genet 1991;49:886—890.

11.

Paw BH , Moskowitz SM , Uhrhammer N. , et al: Juvenile GM2 gangliosidosis caused by substitution of arginine for histidine at position 499 or 504 of the α-subunit of β-hexosaminidase A. J Biol Chem 1990;265:9452—9457.

12.

d'Azzo A. , Proia RL , Kolodny EH , et al: Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency. J Biol Chem 1984;259:11070—11074.

13.

Mark BL , Mahuran DJ , Cherney MM , et al: Crystal structure of human beta-hexosaminidase B: Understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol 2003;327:1093—1109.

14.

Rapin I. , Suzuki K. , Suzuki K. , Valsamis MP : Adult (chronic) GM2 gangliosidosis. Arch Neurol 1976;33:120—130.

15.

Rozenberg R. , Pereira LV : The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program. Sao Paulo Med J 2001;119:146—149.

16.

Neudorfer O. , Kolodny EH : Late-onset Tay-Sachs disease. Isr Med Assoc J 2004;6:107—111.